FATE vs RF
Fate Therapeutics Inc (FATE) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
RF does not have a complete income-statement cache yet.
FATE currently screens at market cap $331.0M. RF currently screens at market cap $0.
Not investment advice. Open the FATE and RF stock pages for the full models.
Not investment advice.